IP Library Granted Patent US 7,670,776
Granted Patent B1
US 7,670,776 · App. 11/781,131 · Granted Mar 2, 2010

MYH gene variants and use thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,670,776
App. No.
11/781,131
Granted
Mar 2, 2010
Kind
B1
Abstract

Variants in MYH gene are disclosed which can result in abnormal synthesis of MYH proteins and alteration of MYH activities. The invention provides methods for detecting the newly discovered genetic variants. Use of MYH genetic variants as biomarkers in diagnosing cancer and detecting a predisposition to cancer are also disclosed herein.

Claims (16)

1. A method for genotyping an individual comprising:

detecting the 691C→T nucleotide variant in an MYH gene obtained from said individual.

2. The method of claim 1 , wherein said detecting step comprises sequencing the MYH gene.

3. The method of claim 1 , wherein a nucleic acid comprising said nucleotide variant is amplified from genomic DNA.

4. The method of claim 1 , wherein said detecting step comprises DNA sequence analysis of the MYH gene.

5. The method of claim 1 , wherein said detecting step comprises amplifying an exon, or fragment thereof, corresponding to the 691C→T nucleotide variant.

6. The method of claim 1 , wherein said MYH gene of said individual is examined for other MYH variants.

7. The method of claim 1 , further comprising embodying results of said detecting step in a transmittable form.

8. A method for determining an increased likelihood for developing colon cancer in an individual, comprising:

determining from a sample obtained from said individual whether said individual has the 691C→T nucleotide variant in an MYH gene of said individual, wherein the presence of said nucleotide variant is indicative of an increased likelihood for developing colon cancer.

9. The method of claim 8 , wherein said determining step comprises sequencing the MYH gene.

10. The method of claim 8 , wherein said determining step comprises amplifying the nucleotide variant from genomic DNA.

11. The method of claim 8 , wherein said sample comprises genomic DNA.

12. The method of claim 8 , wherein said determining step comprises amplifying an exon, or fragment thereof, corresponding to the 691C→T nucleotide variant.

13. The method of claim 8 , wherein said MYH gene of said individual is examined for other MYH variants.

14. The method of claim 8 , further comprising embodying results of said determining step in a transmittable form.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Jul 10, 2023
From: JPMORGAN CHASE BANK, N.A.
To: MYRIAD GENETICS, INC.; CRESCENDO BIOSCENCE, INC.; MYRIAD RBM, INC.; MYRIAD WOMEN'S HEALTH, INC.
Reel/Frame 064239/0091 →
SECURITY INTEREST Recorded Dec 27, 2016
From: MYRIAD GENETICS, INC.
To: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 041198/0578 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 9, 2007
From: SCHOLL, THOMAS; ELIASON, KRISTILYN; JUDKINS, THADDEUS S.
To: MYRIAD GENETICS, INC.
Reel/Frame 020089/0692 →